Johnson & Johnson (JNJ) Raw Materials (2012 - 2018)
Johnson & Johnson (JNJ) posted Raw Materials of $1.1 billion for Q4 2018, down 7.32% sequentially from $1.2 billion in Q3 2018, and down 2.28% YoY from $1.1 billion in Q4 2017.
Johnson & Johnson (JNJ) Raw Materials (2012 - 2018) Analysis & Trends
Johnson & Johnson has reported Raw Materials for 6 years, with the latest figure at $1.1 billion in Q4 2018.
- Quarterly Raw Materials fell 2.28% year-over-year to $1.1 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $1.1 billion (down 2.28% YoY) and the FY2018 annual result came in at $1.1 billion, down 2.28% from the prior year.
- Raw Materials slipped to $1.1 billion in Q4 2018 per JNJ's latest filing, from $1.2 billion in the prior quarter.
- Over five years, Raw Materials peaked at $1.2 billion in Q4 2014 and troughed at $936.0 million in Q1 2016.
- A 4-year average of $1.1 billion and a median of $1.1 billion in 2017 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2016 and 2017: Raw Materials decreased 22.9% in 2016, then climbed 19.75% in 2017.
- Over 4 years, Raw Materials stood at $1.2 billion in 2014, then decreased by 22.9% to $936.0 million in 2016, then increased by 21.79% to $1.1 billion in 2017, then slipped by 2.28% to $1.1 billion in 2018.
- According to Business Quant data, Raw Materials over the past three periods registered $1.1 billion, $1.2 billion, and $1.2 billion for Q4 2018, Q3 2018, and Q3 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 30, 2018 | 1.11 Bn |
| Sep 30, 2018 | 1.20 Bn |
| Jul 1, 2018 | 1.17 Bn |
| Dec 31, 2017 | 1.14 Bn |
| Jan 1, 2017 | 952.00 Mn |
| Jan 3, 2016 | 936.00 Mn |
| Dec 28, 2014 | 1.21 Bn |
| Dec 29, 2013 | 1.22 Bn |
| Dec 30, 2012 | 1.42 Bn |
| Jan 1, 2012 | 1.21 Bn |